(Q42279527)

19 October 2017

Alpha-ketoamide Phe-Pro isostere as a new core structure for the inhibition of HIV protease (English)

1 reference

19 October 2017

Munoz B

1

1 reference

19 October 2017

Giam CZ

series ordinal

2

1 reference

19 October 2017

Wong CH

series ordinal

3

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 October 1994

1 reference

Bioorganic & Medicinal Chemistry

19 October 2017

1 reference

19 October 2017

2

1 reference

19 October 2017

10

1 reference

19 October 2017

1085-1090

1 reference

Human T-lymphotropic retroviruses

19 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982058-1

7 January 2021

Acquired immunodeficiency syndrome: epidemiology, virology, and immunology

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982058-1

7 January 2021

Pathogenesis of lentivirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982058-1

7 January 2021

Current issues in developing a strategy for dealing with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982058-1

7 January 2021

1-(2,3-Anhydro-beta-D-lyxofuranosyl)cytosine derivatives as potential inhibitors of the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982058-1

7 January 2021

Inhibition of HIV-induced cytopathogenicity in vitro by 3'-azido-2',3'-dideoxyguanosine

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982058-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982058-1

1 reference

7 January 2021

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982058-1

7 January 2021

Molecular targets for AIDS therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982058-1

7 January 2021

HTLV-III gag protein is processed in yeast cells by the virus pol-protease

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982058-1

7 January 2021

Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982058-1

7 January 2021

Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982058-1

7 January 2021

Active human immunodeficiency virus protease is required for viral infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982058-1

7 January 2021

Modified oligopeptides designed to interact with the HIV-1 proteinase inhibit viral replication

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982058-1

7 January 2021

A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982058-1

7 January 2021

An 11-kDa form of human immunodeficiency virus protease expressed in Escherichia coli is sufficient for enzymatic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982058-1

7 January 2021

Enzymatic activity of a synthetic 99 residue protein corresponding to the putative HIV-1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982058-1

7 January 2021

A structural model for the retroviral proteases.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982058-1

7 January 2021

Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982058-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982058-1

1 reference

7 January 2021

Substitution of proline with pipecolic acid at the scissile bond converts a peptide substrate of HIV proteinase into a selective inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982058-1

7 January 2021

Amino- and carboxyl-terminal amino acid sequences of proteins coded by gag gene of murine leukemia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982058-1

7 January 2021

HIV protease: a novel chemotherapeutic target for AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982058-1

7 January 2021

Design and synthesis of peptidomimetic inhibitors of HIV-1 protease and renin. Evidence for improved transport

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982058-1

7 January 2021

Renin inhibitors. Synthesis of transition-state analogue inhibitors containing phosphorus acid derivatives at the scissile bond

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982058-1

7 January 2021

Selective phosphinate transition-state analogue inhibitors of the protease of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982058-1

7 January 2021

Potent new inhibitors of human renin

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982058-1

7 January 2021

Novel renin inhibitors containing the amino acid statine

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982058-1

7 January 2021

A series of potent HIV-1 protease inhibitors containing a hydroxyethyl secondary amine transition state isostere: synthesis, enzyme inhibition, and antiviral activity

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982058-1

7 January 2021

Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982058-1

7 January 2021

Peptide alpha-keto ester, alpha-keto amide, and alpha-keto acid inhibitors of calpains and other cysteine proteases

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982058-1

7 January 2021

A simple, continuous fluorometric assay for HIV protease

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2982058-1

7 January 2021

10.1016/S0968-0896(00)82058-1

Identifiers

DOI

1 reference

19 October 2017

1 reference